Q3 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ILMN | Exit | ILLUMINA INC | $0 | – | -6,187 | – | -3.66% | – |
| Exit | CARIBOU BIOSCIENCES INC | $0 | – | -544,196 | – | -7.30% | – |
Q2 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GDX | New | VANECK ETF TRUSTgold miners etf | $22,236,235 | – | 738,500 | – | 70.19% | – |
| ORIC | New | ORIC PHARMACEUTICALS INC | $4,673,631 | – | 602,272 | – | 14.75% | – |
| New | CARIBOU BIOSCIENCES INC | $2,312,833 | – | 544,196 | – | 7.30% | – | |
| YMAB | New | Y-MABS THERAPEUTICS INC | $1,298,276 | – | 191,176 | – | 4.10% | – |
| ILMN | New | ILLUMINA INC | $1,160,001 | – | 6,187 | – | 3.66% | – |
Q4 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ILMN | Exit | ILLUMINA INC | $0 | – | -6,187 | – | -4.01% | – |
| ORIC | Exit | ORIC PHARMACEUTICALS INC | $0 | – | -602,272 | – | -6.55% | – |
| YMAB | Exit | Y-MABS THERAPEUTICS INC | $0 | – | -191,176 | – | -9.37% | – |
| Exit | CARIBOU BIOSCIENCES INC | $0 | – | -544,196 | – | -19.52% | – | |
| GDX | Exit | VANECK ETF TRUSTgold miners etf | $0 | – | -738,500 | – | -60.55% | – |
Q3 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | CARIBOU BIOSCIENCES INC | $5,741,000 | +73.5% | 544,196 | -10.7% | 19.52% | +78.5% |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GDX | New | VANECK ETF TRUSTgold miners etf | $20,220,000 | – | 738,500 | – | 66.82% | – |
| New | CARIBOU BIOSCIENCES INC | $3,308,000 | – | 609,196 | – | 10.93% | – | |
| YMAB | New | Y-MABS THERAPEUTICS INC | $2,892,000 | – | 191,176 | – | 9.56% | – |
| ORIC | New | ORIC PHARMACEUTICALS INC | $2,698,000 | – | 602,272 | – | 8.92% | – |
| ILMN | New | ILLUMINA INC | $1,141,000 | – | 6,187 | – | 3.77% | – |
Q4 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| YMAB | Exit | Y-MABS THERAPEUTICS INC | $0 | – | -216,916 | – | -3.86% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -17,196 | – | -4.35% | – |
| ORIC | Exit | ORIC PHARMACEUTICALS INC | $0 | – | -602,272 | – | -7.85% | – |
| Exit | CARIBOU BIOSCIENCES INC | $0 | – | -674,196 | – | -10.03% | – | |
| GDX | Exit | VANECK ETF TRUSTgold miners etf | $0 | – | -738,500 | – | -13.56% | – |
| RPRX | Exit | ROYALTY PHARMA PLC | $0 | – | -2,680,644 | – | -60.36% | – |
Q3 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | CARIBOU BIOSCIENCES INC | $16,093,000 | – | 674,196 | – | 10.03% | – | |
| ILMN | New | ILLUMINA INC | $6,975,000 | – | 17,196 | – | 4.35% | – |
Q2 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RPRX | New | ROYALTY PHARMA PLC | $109,880,000 | – | 2,680,644 | – | 71.84% | – |
| GDX | New | VANECK VECTORS ETF TRgold miners etf | $25,094,000 | – | 738,500 | – | 16.41% | – |
| ORIC | New | ORIC PHARMACEUTICALS INC | $10,654,000 | – | 602,272 | – | 6.96% | – |
| YMAB | New | Y-MABS THERAPEUTICS INC | $7,332,000 | – | 216,916 | – | 4.79% | – |